Total Funding
64
79
Total FundingPost-IPO Debt raised
Growth Score 64 in past quarter
-8 pts
Heat Score 79 in past quarter
5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
21930
Gelteq is a leader in ingestible gel technology for healthcare, nutrition & sport.
James Pekarsky: Chief Financial OfficerPast Role: BioPharmX, Chief Executive Officer- Nathan Givoni: CEO and Co-Founder
About the Company
​Gelteq is a biotechnology company specializing in the formulation, development, and manufacturing of ingestible gel-based delivery systems for pharmaceuticals, nutraceuticals, pet care, and sports nutrition. The company's proprietary gel technology aims to enhance oral delivery by addressing challenges such as swallowing difficulties and
improving absorption rates.